KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Price-to-earnings ratio
Latest
-3.73
↑ 39% vs avg
Percentile
P83
Within normal range
Streak
2 yr
Consecutive declineElevated
Average
-6.14
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -3.73 | -13.1% |
| 2024 | -3.30 | -23.8% |
| 2023 | -2.66 | +29.6% |
| 2022 | -3.78 | +63.3% |
| 2021 | -10.31 | -55.0% |
| 2020 | -6.65 | +60.1% |
| 2019 | -16.66 | -165.2% |
| 2018 | -6.28 | -66.0% |
| 2017 | -3.79 | +11.4% |
| 2016 | -4.27 | - |